Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
25,08 USD | -0,16 % | -3,69 % | -15,04 % |
14/03 | MIRUM PHARMACEUTICALS, INC. : recomendación de compra de JMP Securities | ZM |
14/03 | Actualización del sector: Las acciones de atención médica fueron mixtas antes del mercado del jueves | MT |
Resumen de negocios
Número de empleados: 264
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapies
100,0
%
| 77 | 100,0 % | 186 | 100,0 % | +141,85 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
82,0
%
| 77 | 100,0 % | 147 | 82,0 % | +90,36 % |
Rest of World
18,0
%
| - | - | 32 | 18,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 45 | 07/05/18 | |
Michael Grey
FOU | Founder | 71 | 07/05/18 |
Peter Radovich
PSD | President | 46 | 28/04/20 |
Eric Bjerkholt
DFI | Director of Finance/CFO | 64 | 11/09/23 |
Pamela Vig
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/12/18 |
Joanne Quan
CTO | Chief Tech/Sci/R&D Officer | 60 | 16/01 |
Paul K. Ross
CMP | Compliance Officer | - | 01/04/20 |
Andrew McKibben
IRC | Investor Relations Contact | - | - |
Erin Campany
HRO | Human Resources Officer | 57 | 01/01/22 |
Corporate Officer/Principal | 54 | 01/12/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 05/04/23 |
Michael Grey
FOU | Founder | 71 | 07/05/18 |
Patrick Heron
BRD | Director/Board Member | 53 | 07/11/18 |
Laurent Fischer
BRD | Director/Board Member | 60 | 01/06/19 |
Laura Brege
BRD | Director/Board Member | 66 | 17/07/19 |
Director/Board Member | 48 | 02/06/22 | |
Founder | 45 | 07/05/18 | |
Lon Cardon
BRD | Director/Board Member | - | 19/12/22 |
William Fairey
BRD | Director/Board Member | 59 | 19/08/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 47 003 329 | 45 058 483 ( 95,86 %) | 0 | 95,86 % |
Información de la empresa
Mirum Pharmaceuticals, Inc.
950 Tower Lane Suite 1050
94404, Foster City
+650 667 4085
http://www.mirumpharma.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,04 % | 1180,72 M | |
+9,30 % | 45,97 mil M | |
+52,73 % | 43,93 mil M | |
+7,15 % | 42,34 mil M | |
-8,78 % | 28,27 mil M | |
+18,68 % | 27,18 mil M | |
-21,92 % | 19,44 mil M | |
+14,62 % | 13,83 mil M | |
+31,85 % | 12,4 mil M | |
+4,47 % | 11,45 mil M |
- Bolsa
- Acciones
- Acción Mirum Pharmaceuticals, Inc. - Nasdaq
- Empresa Mirum Pharmaceuticals, Inc.